Regulus Therapeutics Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
44.17 |
88.38 |
335.57 |
686.88 |
| Przychód Δ r/r |
0.00% |
0.00% |
inf% |
100.10% |
279.68% |
104.69% |
| Przychód (min) |
0.00 |
0.00 |
44.17 |
88.37 |
335.57 |
686.88 |
| Przychód (max) |
0.00 |
0.00 |
44.17 |
88.39 |
335.57 |
686.88 |
| EBITDA (średnia) |
0.00 |
0.00 |
26.50 |
53.03 |
201.34 |
412.13 |
| EBIT (średnia) |
0.00 |
0.00 |
26.50 |
53.03 |
201.34 |
412.13 |
| EBIT % |
0.00% |
0.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-47.52 |
-51.09 |
-73.50 |
20.49 |
97.20 |
233.84 |
| Zysk netto % |
-inf% |
-inf% |
-166.41% |
23.18% |
28.96% |
34.04% |
| EPS (średnia) |
-0.85 |
-0.91 |
-1.06 |
-0.56 |
1.73 |
4.15 |
| Liczba analityków (Przychody) |
0 |
0 |
5 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
4 |
3 |
4 |
2 |
1 |
1 |
| symbol |
RGLS |
RGLS |
RGLS |
RGLS |
RGLS |
RGLS |